Lyme borreliosis (see also stages)
Last Updated: 2023-07-07
Author(s): Anzengruber F., Navarini A.
ICD11: 1C1G
Last Updated: 2023-07-07
Author(s): Anzengruber F., Navarini A.
ICD11: 1C1G
Lyme disease, tick-borne Lyme disease, erythema migrans disease, Lyme borreliosis, Lyme disease, Borrelia burgdorferi infection, European tick-borne Lyme disease.
Ticks (Ixodes ricinus) transmit Borrelia, thread-like, coiled spirochetes, leading to an infectious disease with a variety of symptoms.
3 stages
Plasma cell-rich, perivascular infiltrates are typical.
Therapy according to Lebwohl | Evidence level |
Early stage | |
Doxycycline p.o. 100 mg 2x daily for 14 days | A |
Amoxicillin p.o. 500 mg 3x daily for 14 days | A |
Cefuroxime p.o. 500 mg 2x daily for 14 days | A |
In case of neurological symptoms | |
Cefuroxime i.v. 2g daily for 14 days | B |
Penicillin G i.v. 18-24 million IU daily (in 4 ED) for 14 days | B |
For cardiological symptoms | |
Both oral and intravenous therapy (s.o. possible) | C |
Lyme arthritis without neurological involvement | |
Doxycylcline p.o. 100 mg 2x daily for 14 days | |
Amoxicillin 500 mg 3x daily for 14 days | |
Lyme arthritis with neurological symptoms | |
Ceftriaxone 2 g i.v. daily for 2-3 weeks | B |
Penicillin G 18-24 million IU i.v. (in 4 ED) for 2-3 weeks | |
Chron.-.recurrent arthritides | |
Recurrent antibiotic therapy for 28 days | D |
Late manifestation of neurological symptoms | |
Ceftriaxone 2 g i.v. daily for 2-3 weeks | B |
Penicillin G 18-24 million IU i.v. (in 4 ED) for 2-3 weeks | B |
We Value Your Privacy!
We and our partners are using technologies like cookies and process personal data like the IP-address or browser information in order to personalize the advertising that you see. This helps us to show you more relevant ads and improves your internet experience. We also use it in order to measure results or align our website content. Because we value your privacy, we are herewith asking for your permission to use these technologies. You can always change/withdraw your consent later.